Assertio Holdings, Inc. (ASRT)

6.01 +0.09 (+1.43%) At close: 01:40PM EDT

Assertio Holdings, Inc.

100 South Saunders Road
Suite 300
Lake Forest, IL 60045
United States
224 419 7106
https://www.assertiotx.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 19

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Daniel A. Peisert	Pres, CEO & Director	1.7M	N/A	1975
Mr. Paul Schwichtenberg	Sr. VP & CFO	634.07k	N/A	1971
Mr. Ajay Patel	Sr. VP & Chief Accounting Officer	570.92k	N/A	1984
Mr. Bill Iskos	Sr. VP of Operations	N/A	N/A	N/A
Dr. Jack Hoblitzell Ph.D.	Sr. VP of Technical Operations	N/A	N/A	N/A
Mr. Sam Schlessinger	Sr. VP & Gen. Counsel	N/A	N/A	N/A
Mr. Jeff Christensen	Sr. VP of Commercial	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Corporate Governance

Assertio Holdings, Inc.’s ISS Governance QualityScore as of February 1, 2023 is 3. The pillar scores are Audit: 7; Board: 3; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.